High-Grade Osteosarcoma of the Foot: Presentation, Treatment, Prognostic Factors, and Outcome of 23 Cooperative Osteosarcoma Study Group COSS Patients

Sarcoma
Anne J SchusterStefan S Bielack

Abstract

Osteosarcoma of the foot is a very rare presentation of a rare tumor entity. In a retrospective analysis, we investigated tumor- and treatment-related variables and outcome of patients registered in the Cooperative Osteosarcoma Study Group (COSS) database between January 1980 and April 2016 who suffered from primary high-grade osteosarcoma of the foot. Among the 23 eligible patients, median age was 32 years (range: 6-58 years), 10 were female, and 13 were male. The tarsus was the most commonly affected site (n=16). Three patients had primary metastases. All patients were operated: 5 underwent primary surgery and 18 received surgery following preoperative chemotherapy. In 21 of the 23 patients, complete surgical remission was achieved. In 4 of 17 patients, a poor response to neoadjuvant chemotherapy was observed in the resected primary tumors. Median follow-up was 4.2 years (range: 0.4-18.5). At the last follow-up, 15 of the 23 patients were alive and 8 had died. Five-year overall and event-free survival estimates were 64% (standard error (SE) 12%) and 54% (SE 13%), which is similar to that observed for osteosarcoma in general. Event-free and overall survival correlated with primary metastatic status and completeness of surgery....Continue Reading

References

Feb 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K WinklerV Gerein
Jun 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K WinklerU Göbel
Jan 1, 1983·Journal of Cancer Research and Clinical Oncology·M Salzer-KuntschikR Sigmund
Jul 1, 1982·Klinische Pädiatrie·K WinklerG Landbeck
Mar 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P BielingK Winkler
Jan 16, 1998·The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons·H M OzdemirY Saglik
Sep 16, 1998·Mayo Clinic Proceedings·R BiscagliaP Picci
Nov 24, 1999·Acta Orthopaedica Scandinavica·P F ChoongK K Unni
Feb 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S WeedenUNKNOWN European Osteosarcoma Intergroup
Feb 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stefan S BielackKurt Winkler
Apr 18, 2003·International Orthopaedics·M San-JulianL Sierrasesumaga
May 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leo KagerUNKNOWN Cooperative German-Austrian-Swiss Osteosarcoma Study Group
Jan 22, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Beate Kempf-BielackKurt Winkler
Jun 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gemma GattaUNKNOWN EUROCARE Working Group
Apr 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leo KagerUNKNOWN Cooperative Osteosarcoma Study Group
Aug 10, 2006·International Orthopaedics·Dorothe Carrle, Stefan S Bielack
Aug 22, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C A StillerE Steliarova-Foucher
Feb 14, 2008·Journal of Surgical Oncology·Min Suk KimDae-Geun Jeon
Jul 4, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Enrique González-BillalabeitiaHernán Cortés-Funes
Sep 17, 2009·Foot & Ankle International·Loretta B ChouMartin M Malawer
Sep 29, 2009·Journal of Cancer Research and Clinical Oncology·Matthew T HartingMartin L Blakely
Mar 10, 2010·Cancer Treatment and Research·Stefan BielackRainer Kotz
Apr 1, 1946·Journal of Economic Entomology·F WILCOXON
Oct 22, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J S WhelanH Gelderblom
Dec 6, 2012·Virchows Archiv : an International Journal of Pathology·Jakob K AnningaPancras C W Hogendoorn
Dec 10, 2013·The Lancet Oncology·Gemma GattaUNKNOWN EUROCARE Working Group
Nov 26, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J S WhelanUNKNOWN EURAMOS collaborators

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
amputation
biopsy
surgical remission
amputations

Software Mentioned

SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.